ReproNovo is currently owned by Jeito Capital, through Jeito II, since 2024.

When did Jeito Capital acquire ReproNovo?

Jeito Capital acquired ReproNovo in 2024 (active for 2 years).

ReproNovo

Biotech·

Switzerland·Active·2yr hold

ReproNovo is a healthcare company, headquartered in France.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Most recent investor

2 ownership periods

HQFrance

SectorHealthcare

Basel-based reproductive-health biotech developing therapies for infertility and women's health conditions; Jeito Capital backed in 2024.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Jeito II

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings